CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Eurofins Scientific - ERFp CFD

68.55
0.66%
0.40
Low: 67.35
High: 68.5
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 16:30

Mon - Fri: 08:01 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.40
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024161 %
Charges from borrowed part ($-0.97)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024161%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.020283 %
Charges from borrowed part ($-0.81)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.020283%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 20%
Stock exchange France
Commission on trade 0%

*Information provided by Capital.com

Eurofins Scientific SE ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 68
Open* 67.55
1-Year Change* -25.32%
Day's Range* 67.35 - 68.5
52 wk Range 58.06-100.50
Average Volume (10 days) 520.50K
Average Volume (3 months) 9.60M
Market Cap 13.08B
P/E Ratio 16.48
Shares Outstanding 192.34M
Revenue 6.86B
EPS 4.12
Dividend (Yield %) 1.47406
Beta 0.42
Next Earnings Date Feb 22, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 7, 2023 68.00 -0.20 -0.29% 68.20 68.80 67.15
Feb 6, 2023 70.90 0.30 0.42% 70.60 71.95 70.35
Feb 3, 2023 70.85 2.25 3.28% 68.60 71.00 68.50
Feb 2, 2023 68.90 2.55 3.84% 66.35 69.00 66.15
Feb 1, 2023 65.25 -0.70 -1.06% 65.95 66.70 65.00
Jan 31, 2023 65.55 0.30 0.46% 65.25 65.60 64.25
Jan 30, 2023 65.75 0.70 1.08% 65.05 65.95 64.55
Jan 27, 2023 65.30 0.35 0.54% 64.95 65.50 64.10
Jan 26, 2023 64.75 0.30 0.47% 64.45 64.95 63.85
Jan 25, 2023 63.50 -0.30 -0.47% 63.80 63.90 62.80
Jan 24, 2023 64.15 -0.30 -0.47% 64.45 65.00 63.65
Jan 23, 2023 64.30 0.25 0.39% 64.05 64.35 63.35
Jan 20, 2023 63.70 -0.45 -0.70% 64.15 64.70 63.55
Jan 19, 2023 64.25 -1.70 -2.58% 65.95 66.20 63.85
Jan 18, 2023 66.55 0.35 0.53% 66.20 67.00 66.05
Jan 17, 2023 65.75 1.30 2.02% 64.45 65.95 64.25
Jan 16, 2023 64.80 0.10 0.15% 64.70 65.80 64.50
Jan 13, 2023 64.25 -0.15 -0.23% 64.40 64.65 63.95
Jan 12, 2023 64.90 1.40 2.20% 63.50 65.00 63.45
Jan 11, 2023 63.20 -1.05 -1.63% 64.25 64.80 62.75

Eurofins Scientific Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 2536.61 2971.42 3781.15 4562.8 5438.8 6717.7
Revenue 2536.61 2971.42 3781.15 4562.8 5438.8 6717.7
Cost of Revenue, Total 2056.98 2414.69 3061.3 3632.1 4026.1 4816
Gross Profit 479.624 556.723 719.845 930.7 1412.7 1901.7
Total Operating Expense 2178.99 2571.85 3260.39 3989.3 4415.2 5244.9
Selling/General/Admin. Expenses, Total 0 0 0
Depreciation / Amortization 122.008 157.161 199.085 357.2 389.1 428.9
Other Operating Expenses, Total 0.001
Operating Income 357.615 399.562 520.76 573.5 1023.6 1472.8
Interest Income (Expense), Net Non-Operating -68.698 -42.74 -59.717 -93.2 -97.5 -97
Other, Net 19.91 0.001 -0.001 -3.1 -5.9 -7
Net Income Before Taxes 308.827 356.823 461.042 477.2 920.2 1368.8
Net Income After Taxes 227.465 302.341 356.061 360.3 707.2 1043.4
Minority Interest -3.509 -2.074 0.358 0 -1 -0.4
Net Income Before Extra. Items 223.956 300.267 356.419 360.3 706.2 1043
Total Extraordinary Items -49.959 -83.496 -132.476 -165 -166.7 -260
Net Income 173.997 216.771 223.943 195.3 539.5 783
Total Adjustments to Net Income -35.625 -37.335 -48.624 -49.8 -34.2 -34.5
Income Available to Common Excl. Extra. Items 188.331 262.932 307.795 310.5 672 1008.5
Income Available to Common Incl. Extra. Items 138.372 179.436 175.319 145.5 505.3 748.5
Dilution Adjustment 0 0 0
Diluted Net Income 138.372 179.436 175.319 145.5 505.3 748.5
Diluted Weighted Average Shares 169.57 179.98 183.01 186 195.9 200.6
Diluted EPS Excluding Extraordinary Items 1.11064 1.4609 1.68185 1.66935 3.43032 5.02742
Dividends per Share - Common Stock Primary Issue 0.2 0.24 0.288 0 0.68 1
Diluted Normalized EPS 1.11064 1.4609 1.68185 1.66935 3.43032 5.02742
Q2 2021 Q4 2021
Total revenue 3272.3 3445.4
Revenue 3272.3 3445.4
Cost of Revenue, Total 2264.2 2551.8
Gross Profit 1008.1 893.6
Total Operating Expense 2459 2785.9
Selling/General/Admin. Expenses, Total 0 0
Depreciation / Amortization 194.8 234.1
Operating Income 813.3 659.5
Interest Income (Expense), Net Non-Operating -49.6 -54.4
Net Income Before Taxes 763.7 605.1
Net Income After Taxes 582.9 460.5
Minority Interest -0.4 0
Net Income Before Extra. Items 582.5 460.5
Total Extraordinary Items -166.9 -93.1
Net Income 415.6 367.4
Total Adjustments to Net Income -18.2 -16.3
Income Available to Common Excl. Extra. Items 564.3 444.2
Income Available to Common Incl. Extra. Items 397.4 351.1
Diluted Net Income 397.4 351.1
Diluted Weighted Average Shares 201 200.2
Diluted EPS Excluding Extraordinary Items 2.80746 2.21878
Dividends per Share - Common Stock Primary Issue 0 1
Diluted Normalized EPS 2.80746 2.21878
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 1579.41 1826.58 1705.4 1604.1 2518.2 2319
Cash and Short Term Investments 826.098 820.357 506.246 297 912.4 515.3
Cash 506.019 153.293 24.599 293.4 903.7 497.9
Cash & Equivalents 320.079 667.064 481.647 3.6 8.7 17.4
Total Receivables, Net 605.782 826.799 1043.32 1185 1389.1 1581
Accounts Receivable - Trade, Net 498.014 666.828 807.233 1001.2 1193.5 1389.2
Total Inventory 39.547 51.805 66.373 79.3 157 154.2
Prepaid Expenses 22.432 37.14 42.668 42.6 59.6 68
Other Current Assets, Total 85.554 90.477 46.796 0.2 0.1 0.5
Total Assets 4129.42 5832.31 7205.45 7823.1 8575.5 9332.3
Property/Plant/Equipment, Total - Net 506.818 685.998 1018.01 1593.5 1574.9 1829.9
Property/Plant/Equipment, Total - Gross 1242.93 1661.55 2151.32 3171.5 3344.9 4020.7
Accumulated Depreciation, Total -736.11 -975.549 -1133.31 -1578 -1769.9 -2190.8
Goodwill, Net 1584.64 2505.34 3418.33 3608.8 3524.1 4115.1
Intangibles, Net 383.209 735.12 946.918 918.2 825.1 895.7
Long Term Investments 37.527 49.584 72.626 54.5 56.6 81.7
Other Long Term Assets, Total 37.804 29.69 44.169 44 76.6 90.9
Total Current Liabilities 710.009 1451.89 1450.66 1581.6 1696.4 1855.7
Payable/Accrued 230.122 -0.1
Accrued Expenses 278.76 435.633 560.803 623.7 796.6 874.6
Notes Payable/Short Term Debt -1.215 234.331 372.243 319.5 16.9 80.3
Current Port. of LT Debt/Capital Leases 44.734 319.9 18.832 135.3 220.7 173.5
Other Current Liabilities, Total 157.608 255.886 266.84 271.6 383.4 404.4
Total Liabilities 2501.94 3389.14 4536.26 4984.5 4885.2 4684.6
Total Long Term Debt 1340.36 1662.1 2766.17 3086.9 2917.2 2500.3
Long Term Debt 1331.89 1651.54 2727.22 2646.8 2502.4 2082.1
Capital Lease Obligations 8.472 10.558 38.946 440.1 414.8 418.2
Deferred Income Tax 83.911 126.352 138.557 124.5 115.3 123.6
Minority Interest 129.237 38.803 52.992 59.5 26.1 29.5
Other Liabilities, Total 238.422 109.99 127.88 132 130.2 175.5
Total Equity 1627.48 2443.17 2669.19 2838.6 3690.3 4647.7
Common Stock 1.693 1.764 1.775 1.8 1.9 1.9
Retained Earnings (Accumulated Deficit) 902.209 1457.74 1614.03 1697.1 2853.1 3542.7
Other Equity, Total 723.575 983.668 1053.57 1139.9 835.3 1106.7
Total Liabilities & Shareholders’ Equity 4129.42 5832.31 7205.45 7823.1 8575.5 9332.3
Total Common Shares Outstanding 169.26 176.439 177.522 179.035 190.794 192.214
Accounts Payable 206.143 231.942 231.5 278.9 322.9
Treasury Stock - Common -0.184 -0.2 0 -3.6
Jun 2021 Dec 2021
Total Current Assets 2412.9 2319
Cash and Short Term Investments 639.9 515.3
Cash & Equivalents 639.9 515.3
Total Receivables, Net 1405.3 1465.9
Accounts Receivable - Trade, Net 1316 1389.2
Total Inventory 169.1 154.2
Prepaid Expenses 198.4 183.1
Other Current Assets, Total 0.2 0.5
Total Assets 8661 9332.3
Property/Plant/Equipment, Total - Net 1667.3 1829.9
Goodwill, Net 3643.3 4115.1
Intangibles, Net 814.9 895.7
Long Term Investments 61.5 81.7
Other Long Term Assets, Total 61.1 90.9
Total Current Liabilities 1758.1 1855.7
Payable/Accrued 530.8 627.6
Accrued Expenses 44.4 31.4
Notes Payable/Short Term Debt 0 0
Current Port. of LT Debt/Capital Leases 128.2 253.8
Other Current Liabilities, Total 1054.7 942.9
Total Liabilities 4581.8 4684.6
Total Long Term Debt 2526.8 2500.3
Long Term Debt 2526.8 2500.3
Deferred Income Tax 116.2 123.6
Minority Interest 31 29.5
Other Liabilities, Total 149.7 175.5
Total Equity 4079.2 4647.7
Common Stock 1.9 1.9
Retained Earnings (Accumulated Deficit) 3132.2 3542.7
Other Equity, Total 945.1 1106.7
Total Liabilities & Shareholders’ Equity 8661 9332.3
Total Common Shares Outstanding 191.329 192.214
Treasury Stock - Common -3.6
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 242.607 250.105 289.84 271.5 694.4 1056.6
Cash From Operating Activities 371.841 405.122 543.894 677.8 1223.5 1509.9
Cash From Operating Activities 141.696 175.718 223.747 395.9 426 450.7
Non-Cash Items 67.414 28.645 41.124 69.6 142.8 207
Cash Taxes Paid 73.239 79.384 67.816 95 94 296.7
Cash Interest Paid 55.222 45.612 59.983 93.3 67.8 168.8
Changes in Working Capital -79.876 -90.121 -88.622 -159.2 -142.5 -302
Cash From Investing Activities -391.803 -1747.09 -1557.45 -540.2 -525 -1034.2
Capital Expenditures -199.675 -245.735 -364.449 -425.1 -355.5 -519.5
Other Investing Cash Flow Items, Total -192.128 -1501.35 -1193 -115.1 -169.5 -514.7
Cash From Financing Activities 49.903 1343.29 691.064 -342.2 -48.6 -910.3
Financing Cash Flow Items -90.849 317.307 -108.706 -461.9 -104.5 -335.4
Total Cash Dividends Paid -22.452 -34.912 -42.645 -51.1
Issuance (Retirement) of Stock, Net 501.118 320.049 20.041 23.4 564.8 32.2
Issuance (Retirement) of Debt, Net -337.914 740.848 822.374 147.4 -508.9 -607.1
Foreign Exchange Effects 4.674 -10.969 1.465 4.1 -33.9 39.1
Net Change in Cash 34.615 -9.641 -321.023 -200.5 616 -395.5
Amortization 40.775 77.805 100 102.8 97.6
Jun 2021 Dec 2021
Net income/Starting Line 578.8 1056.6
Cash From Operating Activities 708.6 1509.9
Cash From Operating Activities 204.4 450.7
Non-Cash Items 192.8 304.6
Cash Taxes Paid 139.9 296.7
Cash Interest Paid 135.8 168.8
Changes in Working Capital -267.4 -302
Cash From Investing Activities -276.5 -1034.2
Capital Expenditures -223 -519.5
Other Investing Cash Flow Items, Total -53.5 -514.7
Cash From Financing Activities -718.7 -910.3
Financing Cash Flow Items -150.4 -335.4
Total Cash Dividends Paid -0.4
Issuance (Retirement) of Stock, Net 12.6 32.2
Issuance (Retirement) of Debt, Net -580.5 -607.1
Foreign Exchange Effects 14.7 39.1
Net Change in Cash -271.9 -395.5
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Family (Gilles Martin) Other Insider Investor 32.7621 63145480 0 2022-10-24 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.6517 5110825 497156 2022-12-31 LOW
Capital Research Global Investors Investment Advisor 2.1126 4071885 2346140 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.772 3415358 186 2022-12-31 LOW
Allianz Global Investors GmbH Investment Advisor 1.7115 3298735 10351 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4551 2804489 130325 2022-12-31 LOW
Impax Asset Management Ltd. Investment Advisor 1.3688 2638300 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.3249 2553659 13084 2023-01-31 LOW
FMR Investment Management (U.K.) Limited Investment Advisor 1.3171 2538574 -9500 2022-12-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.2415 2392913 380 2022-12-31 LOW
1832 Asset Management L.P. Investment Advisor 1.1023 2124655 314999 2022-09-30 LOW
Mawer Investment Management Ltd. Investment Advisor 1.0868 2094699 38093 2022-12-31 LOW
Ruane, Cunniff & Goldfarb L.P. Investment Advisor 0.9979 1923273 415107 2022-09-30 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.9334 1799105 64223 2022-12-31 HIGH
T. Rowe Price Associates, Inc. Investment Advisor 0.8623 1662046 -845338 2022-12-31 LOW
Jupiter Asset Management Ltd. Investment Advisor/Hedge Fund 0.7381 1422581 2545 2022-10-31 LOW
Union Investment Privatfonds GmbH Investment Advisor 0.6808 1312181 -110462 2022-09-30 LOW
T. Rowe Price International Ltd Investment Advisor/Hedge Fund 0.6156 1186565 69099 2022-12-31 MED
Credit Suisse Asset Management Investment Advisor/Hedge Fund 0.5994 1155282 1954 2022-12-31 LOW
Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.5596 1078488 0 2022-12-31 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+500000+

Traders

93000+

Active clients monthly

$57000000+

Monthly investing volume

$31000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Eurofins Company profile

Eurofins Scientific is an international laboratory testing company, founded in 1987 and headquartered in Luxembourg. Through its subsidiaries, the company offers environmental, pharmaceutical products and food testing, as well as the key emerging specialty clinical diagnostic testing.

The company prides itself on performing over 400 million tests each year and holding over 200,000 validated analytical methods in its portfolio. With over 45,000 employees, Eurofins Scientific operates a global network of 800 laboratories in 47 countries.

Eurofins operates through an extensive network of laboratories, including Institut Nehring GmbH in Germany, VRL Laboratories in the United States, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. Eurofins also have subsidiaries in Eastern Canada, Brazil, and Japan.

One of the fastest-growing companies in Europe, Eurofins Scientific is known for its aggressive expansion strategy, as it has bought more than 80% of its competitors worldwide. Since it went public in 1997 on the French stock exchange, Eurofins has been reporting a 35% growth in sales each year with 3.7 billion Euro in 2018.

The Eurofins share price is quoted on Euronext Paris and featured in the CAC Mid 60 Index. Find out an updated Eurofins company profile, the latest company news and the most current Eurofins share price data at Capital.com.

Industry: Testing Laboratories

23 Val Fleuri
LUXEMBOURG
1526
LU

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,678.30 Price
-0.190% 1D Chg, %
Long position overnight fee -0.0186%
Short position overnight fee 0.0075%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

78.55 Price
+0.730% 1D Chg, %
Long position overnight fee -0.0218%
Short position overnight fee 0.0068%
Overnight fee time 22:00 (UTC)
Spread 0.03

XRP/USD

0.40 Price
-0.240% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00323

Natural Gas

2.56 Price
-2.510% 1D Chg, %
Long position overnight fee -0.1071%
Short position overnight fee 0.0755%
Overnight fee time 22:00 (UTC)
Spread 0.005

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading